Antimicrobial Resistance, from bench-to-publicside




public health, antibiotic resistance, education, infectious diseases


Antibiotic resistance is a growing worldwide problem, which challenge current therapeutic approaches. Several predictions alerts about millions of deaths by 2050, with additional enormous economical losses, related to the increasing loss of activity of antibiotics. A rationale use of antibiotics is essential to fight antibiotic resistance, but all actions, decisions and policies focused to limit the antibiotic uses to those strictly necessaries need for the support of the society. Raising public awareness is the only way to be successful in this endeavor.


Ruiz J. La prehistoria de los antimicrobianos. In: Barriobero Neiva JI, Soldevilla Armas A, editors. Un Breve Viaje por la Ciencia, Logroño [Spain]: Universidad de La Rioja; 2005, p. 41-44.

Pons MJ, de Toro M, Medina S, Saénz Y, Ruiz J. Antimicrobianos, resistencia antibacteriana y salud sostenible. S Sustainability. 2020; 1(1): 7-10.

Ruiz J. Reflexión acerca del concepto de “Una salud”. Rev Peru Med Exp Salud Publica. 2018; 35: 657-62.

MacVane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med. 2014; 9:232-8.

O'Neill J (chair). Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. London, UK: HM Government/ Wellcome Trust, 2014. Accessed on August 25, 2021

Jonas OB, Irwin A, Bertthe FCJ, Le Gall FG, Marquez PV. Drug-Resistant Infections: a Threat to Our Economic Future (Vol. 2): Final Report, Washington, D.C.: World Bank Group; 2017.




How to Cite

Ruiz, J. (2021). Antimicrobial Resistance, from bench-to-publicside. Microbes, Infection and Chemotherapy, 1, e1182.